Literature DB >> 19633668

Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells.

Emilie Rass1, Anastazja Grabarz, Isabelle Plo, Jean Gautier, Pascale Bertrand, Bernard S Lopez.   

Abstract

Here we have used an intrachromosomal substrate to monitor the end joining of distant ends, which leads to DNA rearrangements in mammalian cells. We show that silencing Mre11 reduces the efficiency of nonhomologous end joining (NHEJ), affecting both the canonical and alternative pathways, partly in a manner that is independent of the ataxia-telangiectasia mutated kinase (ATM). Silencing of Rad50 or CtIP decreases end-joining efficiency in the same pathway as Mre11. In cells defective for Xrcc4, the MRE11-RAD50-NBS1 (MRN) complex inhibitor MIRIN decreases end-joining frequencies, demonstrating a role for MRN in alternative NHEJ. Consistently, MIRIN sensitizes both complemented and NHEJ-defective cells to ionizing radiation. Conversely, overexpression of Mre11 stimulates the resection of single-stranded DNA and increases alternative end joining, through a mechanism that requires Mre11's nuclease activity, but in an ATM-independent manner. These data demonstrate that, in addition to its role in ATM activation, Mre11 can favor alternative NHEJ through its nuclease activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633668     DOI: 10.1038/nsmb.1641

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  62 in total

1.  Biochemical evidence for Ku-independent backup pathways of NHEJ.

Authors:  Huichen Wang; Ange Ronel Perrault; Yoshihiko Takeda; Wei Qin; Hongyan Wang; George Iliakis
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

2.  Formation of NHEJ-derived reciprocal chromosomal translocations does not require Ku70.

Authors:  David M Weinstock; Erika Brunet; Maria Jasin
Journal:  Nat Cell Biol       Date:  2007-08       Impact factor: 28.824

3.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

4.  Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts.

Authors:  Qing Zhong; Thomas G Boyer; Phang-Lang Chen; Wen-Hwa Lee
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

5.  Characterization of homologous recombination induced by replication inhibition in mammalian cells.

Authors:  Y Saintigny; F Delacôte; G Varès; F Petitot; S Lambert; D Averbeck; B S Lopez
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

6.  PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites.

Authors:  Jean-François Haince; Darin McDonald; Amélie Rodrigue; Ugo Déry; Jean-Yves Masson; Michael J Hendzel; Guy G Poirier
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

7.  Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends.

Authors:  Josée Guirouilh-Barbat; Emilie Rass; Isabelle Plo; Pascale Bertrand; Bernard S Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

8.  Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex.

Authors:  Ji-Hoon Lee; Tanya T Paull
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

Review 9.  Gene conversion: mechanisms, evolution and human disease.

Authors:  Jian-Min Chen; David N Cooper; Nadia Chuzhanova; Claude Férec; George P Patrinos
Journal:  Nat Rev Genet       Date:  2007-09-11       Impact factor: 53.242

10.  DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1.

Authors:  Grzegorz Ira; Achille Pellicioli; Alitukiriza Balijja; Xuan Wang; Simona Fiorani; Walter Carotenuto; Giordano Liberi; Debra Bressan; Lihong Wan; Nancy M Hollingsworth; James E Haber; Marco Foiani
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

View more
  186 in total

1.  Dual functions of Nbs1 in the repair of DNA breaks and proliferation ensure proper V(D)J recombination and T-cell development.

Authors:  Amal Saidi; Tangliang Li; Falk Weih; Patrick Concannon; Zhao-Qi Wang
Journal:  Mol Cell Biol       Date:  2010-10-04       Impact factor: 4.272

2.  Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Authors:  Anastazja Grabarz; Aurélia Barascu; Josée Guirouilh-Barbat; Bernard S Lopez
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

Review 3.  Origin of chromosomal translocations in lymphoid cancer.

Authors:  André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

4.  Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes.

Authors:  Marcela P Cataldi; Douglas M McCarty
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

5.  Autophosphorylation and ATM activation: additional sites add to the complexity.

Authors:  Sergei V Kozlov; Mark E Graham; Burkhard Jakob; Frank Tobias; Amanda W Kijas; Marcel Tanuji; Philip Chen; Phillip J Robinson; Gisela Taucher-Scholz; Keiji Suzuki; Sairai So; David Chen; Martin F Lavin
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

6.  Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1).

Authors:  Cristian Boboila; Valentyn Oksenych; Monica Gostissa; Jing H Wang; Shan Zha; Yu Zhang; Hua Chai; Cheng-Sheng Lee; Mila Jankovic; Liz-Marie Albertorio Saez; Michel C Nussenzweig; Peter J McKinnon; Frederick W Alt; Bjoern Schwer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

7.  Decoding non-random mutational signatures at Cas9 targeted sites.

Authors:  Amir Taheri-Ghahfarokhi; Benjamin J M Taylor; Roberto Nitsch; Anders Lundin; Anna-Lina Cavallo; Katja Madeyski-Bengtson; Fredrik Karlsson; Maryam Clausen; Ryan Hicks; Lorenz M Mayr; Mohammad Bohlooly-Y; Marcello Maresca
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

Review 8.  BRCA1 Mutation: A Predictive Marker for Radiation Therapy?

Authors:  Charlene Kan; Junran Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-01       Impact factor: 7.038

Review 9.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

10.  DNA end resection is needed for the repair of complex lesions in G1-phase human cells.

Authors:  Nicole B Averbeck; Oliver Ringel; Maren Herrlitz; Burkhard Jakob; Marco Durante; Gisela Taucher-Scholz
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.